secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0000064803-22-000037
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Q3 GAAP loss $(2.60) on opioid/LTC charges; adj. EPS $2.09 beat; raises full-year adj. guidance
--------------------------------------------------------------------------------

- Total revenues $81.2B (+10.0% YoY); GAAP diluted loss per share $(2.60) vs $1.20 EPS prior year.
- GAAP results include $5.2B pre-tax opioid litigation charge and $2.5B pre-tax loss on LTC business held for sale.
- Adjusted EPS of $2.09 vs $1.97 prior year; full-year adj. EPS guidance raised to $8.55-$8.65 from $8.40-$8.60.
- Full-year GAAP EPS guidance lowered to $3.12-$3.22 from $7.23-$7.43 due to the charges.
- Agreed to acquire Signify Health for $30.50/share (~$8B total); repaid $2.6B debt and paid $726M dividends in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480322000037/0000064803-22-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480322000037/cvs-20221102.htm
  HTML page:      https://secwatch.observer/filing/0000064803-22-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer